BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 6, 2026
See today's BioWorld Asia
Home
» Lack of free market policies pushes biopharmas away from Pakistan
To read the full story,
subscribe
or
sign in
.
Lack of free market policies pushes biopharmas away from Pakistan
May 24, 2017
By
Khawar Khan
KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of more than 200 million.
BioWorld Asia